LONDON (Alliance News) - Regenerative medical devices company Tissue Regenix Group PLC on Friday said it has won a contract with an unnamed US group purchasing organisation for its DermaPure wound care product.
The organisation negotiates contracts and pricing with a network on behalf of its members, which can include regional alliances, hospitals and individual physician offices, Tissue Regenix said.
Tissue Regenix said it has secured a three-year contract with the organisation, which spans 43 states and is affiliated with over 48 integrated delivery networks.
Tissue Regenix shares were up 6.3% to 17.80 pence per share on Friday.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Tissue Regenix Group (TRX)